Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PI 5 P 4 K inhibitors: promising opportunities and challenges

FEBS Journal(2025)10.1111/febs.17393Source: DataRank Database

PI 5 P 4 K inhibitors: promising opportunities and challenges is a research paper published in FEBS Journal (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 1.30)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Lisa Nagase,Shun Kageyama ORCID,Hirotaka Kanoh,Masashi Oshima ORCID,Aki Iio ORCID

Live enrichment

PubMed:39828902 PMC:PMC12276927 OpenAlex:https://openalex.org/W4406593511

Human Frontier Science Program

Grant: RGP0028/2022

Japan Society for the Promotion of Science

Grant: 20H03165

Japan Society for the Promotion of Science

Grant: 22J12765

Japan Society for the Promotion of Science

Grant: 22K18374

Japan Society for the Promotion of Science

Grant: 23K05683

Center for Scientific Review

Grant: R01GM144426

Japan Agency for Medical Research and Development

Grant: 22ama221112h0001

Japan Agency for Medical Research and Development

Grant: 24gm1610003h0204

Japan Agency for Medical Research and Development

Grant: JP23ama121001

Japan Agency for Medical Research and Development

Grant: JP23gm1710007

Terumo Life Science Foundation

Grant: 23-III4028

CREST Program

Grant: JPMJCR20H6k

Astellas Foundation for Research on Metabolic Disorders

Naito Foundation

Takeda Science Foundation

Japan Science and Technology Agency

Naito Foundation

Japan Science and Technology Agency

Takeda Science Foundation

Astellas Foundation for Research on Metabolic Disorders

FWCI

1.30

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.17393

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.17393

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/febs.17393

journalhttps://doi.org/10.1111/febs.17393

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39828902

Fields of Study

Protein Degradation and InhibitorsCellular transport and secretionPhagocytosis and Immune RegulationMedicineChemistryHumansAnimalsNeoplasmsPhosphotransferases (Alcohol Group Acceptor)Protein Kinase InhibitorsIsoenzymesAdenosine TriphosphateNeurodegenerative Diseases

MeSH Terms

Adenosine TriphosphateAnimalsHumansIsoenzymesNeoplasmsPhosphotransferases (Alcohol Group Acceptor)Neurodegenerative DiseasesProtein Kinase Inhibitors

Keywords

GTP'KinaseIsozymeBiologyAllosteric regulationIn vivoCell biologyBiochemistryEnzymeGeneticsCancerPhosphoinositidePI3KDrug DevelopmentScaffolding FunctionPi4p5k/pipki/type I PipkPi5p4k/pipkii/type Ii Pipk

Sustainable Development Goals

SDG 0: Good health and well-being